Eli Lilly (LLY) Net Income (2009 - 2026)
Eli Lilly (LLY) reported Net Income of $7.1 billion for Q2 2026, up 25.3% from $5.66 billion a year earlier but down 4.1% from the prior quarter.
Eli Lilly (LLY) Net Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eli Lilly's Net Income came in at $26.71 billion, up 93.6% year-over-year; for FY2025, it was $20.64 billion, up 94.9% from FY2024.
- Net Income has a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
- By year, Net Income came in at $10.59 billion in FY2024 (+102.1%), $5.24 billion in FY2023 (-16.1%), $6.24 billion in FY2022 (+11.9%) and $5.58 billion in FY2021 (-9.9%).
- Five-year quarterly Net Income spans a low of -$57.4 million in Q3 2023 and a high of $7.4 billion in Q1 2026.
- Year over year, Net Income has now increased in each of the last seven quarters, with growth averaging 133.5% over the last seven quarters.
- The high point for year-over-year Net Income in five years was Q3 2025 (growth of 475.3%); the low point was Q2 2022 (a decline of 31.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.4 billion (Q1 2026), $6.64 billion (Q4 2025) and $5.58 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.10 Bn |
| Mar 31, 2026 | 7.40 Bn |
| Dec 31, 2025 | 6.64 Bn |
| Sep 30, 2025 | 5.58 Bn |
| Jun 30, 2025 | 5.66 Bn |
| Mar 31, 2025 | 2.76 Bn |
| Dec 31, 2024 | 4.41 Bn |
| Sep 30, 2024 | 970.30 Mn |
| Jun 30, 2024 | 2.97 Bn |
| Mar 31, 2024 | 2.24 Bn |
| Dec 31, 2023 | 2.19 Bn |
| Sep 30, 2023 | -57.40 Mn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.94 Bn |
| Sep 30, 2022 | 1.45 Bn |
| Jun 30, 2022 | 952.50 Mn |
| Mar 31, 2022 | 1.90 Bn |
| Dec 31, 2021 | 1.73 Bn |
| Sep 30, 2021 | 1.11 Bn |
Eli Lilly Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=LLY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();